Identifying the critical step is crucial for fully understanding the molecular mechanisms underlying the LY6E-mediated activation of HIF-1, which will, in turn, assist in developing inhibitors of the LY6E-HIF-1 axis for cancer therapy. Here, HIF1A is linked to cancer.